InnovAge (INNV) 10% Owner L.P. Sells $14M of Stock
Key Points
- Welsh, Carson, Anderson & Stowe XII, L.P. sold 1,500,000 shares of InnovAge Holding Corp. at $9.25 per share on October 21, 2026, lowering its stake by about 1.5% to 101,076,555 shares.
- InnovAge Holding Corp. trades recently around $9.55, sitting below its 50-day moving average but above its 200-day moving average.
- The medical care facility provider reported trailing twelve month revenue of $989.7 million alongside a next earnings date of November 3, 2026.
Since the trade, $INNV is up 4.5% to date (from the $9.14 close on Oct 21, 2026).
Get InnovAge Holding Corp. text alerts
We text you when insiders, Congress, analysts or big funds move on $INNV.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated InnovAge Holding Corp. alert may contain errors. Disclosures
Welsh, Carson, Anderson & Stowe XII, L.P., a 10% owner of InnovAge Holding Corp. (NasdaqGS: INNV), sold 1,500,000 shares on October 21, 2026. According to a Form 4 filed with the SEC, the shares were sold at a price of $9.25 each, totaling roughly $13.88 million.
Inside Welsh, Carson's InnovAge Trade
The major shareholder parted with 1,500,000 shares in the transaction, reducing its holdings by about 1.5% to 101,076,555 shares. This follows several other large disposals by major holders connected to the company in recent weeks.
Other Institutional Activity in InnovAge Holding Corp.
Federated Hermes, Inc. grew its holdings by 1,899,133 shares, ending with 1,903,713 shares worth about $18.18 million. Arrowstreet Capital, Limited Partnership grew its holdings by 251,196 shares, ending with 668,742 shares worth about $6.39 million. Algert Global, LLC grew its holdings by 563,735 shares, ending with 630,520 shares worth about $6.02 million. Acadian Asset Management. LLC grew its holdings by 207,671 shares, ending with 390,850 shares worth about $3.73 million.
InnovAge Holding Corp. Stock Up 4.5%
InnovAge Holding Corp. shares recently traded around $9.55 as of October 23, 2026. The stock sits about 4.7% below its 50-day moving average of $10.02 and about 6.7% above its 200-day moving average of $8.95. Shares remain down roughly 24.4% from their 52-week high of $12.64 and well above their 52-week low of $3.94.
Recent Earnings
The medical care provider generated $989.7 million in trailing twelve month revenue with negative earnings per share of $0.02. The company's next financial results are scheduled for release on November 3, 2026.
Insider Buying and Selling at InnovAge Holding Corp.
Several large owners trimmed their stakes prior to this filing. L.P. Tco Group Holdings sold 10,000,000 shares on September 24, 2026, for $92.5 million. Ignite Aggregator L.P. sold 10,000,000 shares on the same day for $92.5 million. Welsh, Carson, Anderson & Stowe Xii, L.P. also disposed of 10,000,000 shares on September 24, 2026, for $88.4 million. Officer Nicole Damato sold 23,814 shares on September 25, 2026, for $207,182.
Analysts Set New Price Targets
Keybanc upgraded the stock to an Overweight rating with a $13.0 target on August 21, 2026, and later maintained that rating while raising its target to $14.0 on September 9, 2026. Analysts currently maintain a consensus mean price target of $12.0.
About InnovAge Holding Corp.
Headquartered in Denver, Colorado, InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors. The company operates through its Program of All-Inclusive Care for the Elderly model, helping older adults live independently.
Bottom Line
Investors will look ahead to the company's upcoming earnings report on November 3, 2026, for further updates on financial performance and operational progress.
Source: Welsh, Carson, Anderson & Stowe XII, L.P.'s Form 4 filing on $INNV (Oct 21, 2026). Written by software, not financial advice. How we make alerts